Information
Learning Objective 1
Understand the bi-directional microbiota-gut–brain axis interaction and integrate the relevance of gut dysbiosis to translational epilepsy research
Learning Objective 2
Recognize that gut bacteria and their metabolites influence seizure susceptibility and modify the efficacy of anti-seizure medications
Learning Objective 3
Identify that targeting the gut microbiota represents a potential therapeutic option to reduce both peripheral and brain inflammation and ameliorate seizure burden and epilepsy-related behavioral comorbidities
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Session ID
GUTIW26
Presentation Id
3451966
Event ID
24056
Session Type
Session

